Therapy News and Research

RSS

Is gout a risk factor for COVID-19?

A team of international scientists has recently determined the association between gout and risk of coronavirus disease 2019 (COVID-19) related death in a large cohort of patients. Their findings reveal that gout can significantly increase the risk of COVID-19 and related mortality, with women having a higher risk than men. The study is currently available on the medRxiv* preprint server.

4 Oct 2021

Research highlights how support services have helped sexual abuse survivors during the pandemic

The impact of the Covid-19 pandemic on sexual abuse survivors going through the criminal justice system has been 'huge' with support services reporting referral increases of up to 366 per cent.

4 Oct 2021

New campaign launched to help adults improve their mental wellbeing

The general public is urged to find "what works for me" to support their mental wellbeing as the Office for Health Improvement and Disparities (OHID) launches the latest  Better Health - Every Mind Matters (EMM) campaign.

4 Oct 2021

On-demand brain stimulation alleviates severe depression

The study, which appears in the Oct. 4, 2021, issue of Nature Medicine, represents a landmark success in the years-long effort to apply advances in neuroscience to the treatment of psychiatric disorders.

4 Oct 2021

Novel app to track and improve recovery for stroke survivors with aphasia

A smartphone app to track and improve communication recovery for stroke survivors with aphasia is under development by University of Queensland researchers.

4 Oct 2021

Psychedelic drug changes the emotional state of people listening to music

Scientists have found that the psychedelic drug psilocybin, in development as an anti-depressive treatment, changes the emotional state of people listening to music.

4 Oct 2021

Study finds cause and solution for complications in peritoneal dialysis

The number of patients suffering from chronic kidney disease or loss of kidney function is increasing worldwide and with it the number of people who need renal replacement therapy.

4 Oct 2021

Key lessons from COVID-19 pandemic for scientific and clinical communities

In a paper published in the journal Cell, researchers have investigated and criticized clinical care management and drug administration within the pandemic.

4 Oct 2021

Existing drug used to treat constipation may boost people's ability to think more clearly

The development of drugs to treat cognitive problems in patients with mental illness may be a step closer after a team of researchers discovered that an existing drug - used to treat constipation - may be able to boost our ability to think more clearly.

4 Oct 2021

REGEN-COV shown to reduce risk of COVID-19–related hospitalization or death from any cause

The phase 1-2 clinical trials conducted using REGEN-COV had shown promising therapeutic benefits in COVID-19 outpatients. Its effect was further investigated in the present phase 3 clinical trial, the findings of which have been published in the "The New England Journal of Medicine".

3 Oct 2021

Northwestern’s SPORE has made advances in understanding the genetic basis of glioblastoma

Glioblastoma is one of the deadliest cancers known to man. While the advent of immunotherapy and other cutting-edge treatments have prolonged life for people afflicted with other types of cancer, the prognosis for glioblastoma has remained relatively constant: just 18 months.

3 Oct 2021

Research reveals key differences between childhood and adult chronic spontaneous urticaria

New research presented at EADV 30th Congress today unveils key insights on the characteristic differences in chronic spontaneous urticaria in children versus adults.

3 Oct 2021

Depressed adolescents' brains give a muted reaction to distressing images, research finds

Scientists have measured brain activity in young people with and without depression, and found that the brains of depressed adolescents give a muted reaction to distressing images.

3 Oct 2021

Restoring visual function after stroke with gene therapy

Most strokes happen when an artery in the brain becomes blocked. Blood flow to the neural tissue stops, and those tissues typically die. Because of the locations of the major arteries in the brain, many strokes affect motor function.

3 Oct 2021

Limited options for managing UTIs make women fearful and frustrated

Despite the prevalence of the painful condition, women are fearful and frustrated with limited management options, according to Cedars-Sinai research published in the Journal of Urology.

2 Oct 2021

Osimertinib offers a hint of added benefit for NSCLC patients who have received adjuvant chemotherapy

Osimertinib was the first drug to be approved for adjuvant treatment after complete tumour resection in adults with stage IB to IIIA non-small cell lung cancer (NSCLC).

2 Oct 2021

Research on wandering thoughts may offer clues about mental health

Where does your mind wander when you have idle time? A University of Arizona-led study published in Scientific Reports may offer some clues, and the findings reveal a surprising amount about our mental health.

2 Oct 2021

Cancer patients on chemotherapy have lower immune response to COVID-19 vaccine, study finds

The COVID-19 pandemic has been an especially stressful time for cancer patients undergoing chemotherapy, which attacks not only the cancer, but also the immune cells needed to defend the body from infections.

2 Oct 2021

WHO's new List of Essential Medicines prioritizes access to diabetes and cancer treatments

WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials to treat serious bacterial and fungal infections.

1 Oct 2021

Novel Assay Platform for 3D Microfluidic Cancer Research

AMSBIO have supplied custom Chimeric antigen receptor (CAR)-T products to the University of Strathclyde (UoS) in Glasgow, UK, and ScreenIn3D Ltd, allowing them to perform novel immune-oncology assays in 3D microfluidic cancer models.

From AMS Biotechnology 1 Oct 2021

Therapy News and Research

Is gout a risk factor for COVID-19?

Research highlights how support services have helped sexual abuse survivors during the pandemic

New campaign launched to help adults improve their mental wellbeing

On-demand brain stimulation alleviates severe depression

Novel app to track and improve recovery for stroke survivors with aphasia

Psychedelic drug changes the emotional state of people listening to music

Study finds cause and solution for complications in peritoneal dialysis

Key lessons from COVID-19 pandemic for scientific and clinical communities

Existing drug used to treat constipation may boost people's ability to think more clearly

REGEN-COV shown to reduce risk of COVID-19–related hospitalization or death from any cause

Northwestern’s SPORE has made advances in understanding the genetic basis of glioblastoma

Research reveals key differences between childhood and adult chronic spontaneous urticaria

Depressed adolescents' brains give a muted reaction to distressing images, research finds

Restoring visual function after stroke with gene therapy

Limited options for managing UTIs make women fearful and frustrated

Osimertinib offers a hint of added benefit for NSCLC patients who have received adjuvant chemotherapy

Research on wandering thoughts may offer clues about mental health

Cancer patients on chemotherapy have lower immune response to COVID-19 vaccine, study finds

WHO's new List of Essential Medicines prioritizes access to diabetes and cancer treatments

Novel Assay Platform for 3D Microfluidic Cancer Research

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News